...
首页> 外文期刊>Frontiers in Immunology >Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses
【24h】

Monitoring T-Cell Responses in Translational Studies: Optimization of Dye-Based Proliferation Assay for Evaluation of Antigen-Specific Responses

机译:监测转化研究中的T细胞反应:评估抗原特异性反应的基于染料的增殖分析的优化

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Adoptive therapy with regulatory T cells or tolerance-inducing antigen (Ag)-presenting cells is innovative and promising therapeutic approach to control undesired and harmful activation of the immune system, as observed in autoimmune diseases, solid organ and bone marrow transplantation. One of the critical issues to elucidate the mechanisms responsible for success or failure of these therapies and define the specificity of the therapy is the evaluation of the Ag-specific T-cell responses. Several efforts have been made to develop suitable and reproducible assays. Here, we focus on dye-based proliferation assays. We highlight with practical examples the fundamental issues to take into consideration for implementation of an effective and sensitive dye-based proliferation assay to monitor Ag-specific responses in patients. The most critical points were used to design a road map to set up and analyze the optimal assay to assess Ag-specific T-cell responses in patients undergoing different treatments. This is the first step to optimize monitoring of tolerance induction, allowing comparison of outcomes of different clinical studies. The road map can also be applied to other therapeutic interventions, not limited to tolerance induction therapies, in which Ag-specific T-cell responses are relevant such as vaccination approaches and cancer immunotherapy.
机译:如在自身免疫性疾病,实体器官和骨髓移植中所观察到的那样,采用调节性T细胞或耐受性诱导抗原(Ag)呈递细胞的过继治疗是控制免疫系统不良和有害激活的创新且有前途的治疗方法。阐明导致这些疗法成功或失败的机制并定义疗法特异性的关键问题之一是评估Ag特异性T细胞反应。为了开发合适的和可重复的测定,已经做出了一些努力。在这里,我们专注于基于染料的增殖测定。我们以实际的例子突出显示了实施有效和敏感的基于染料的增殖测定法以监测患者的Ag特异性反应时要考虑的基本问题。最关键的点用于设计路线图,以建立和分析最佳方法,以评估接受不同治疗的患者的Ag特异性T细胞反应。这是优化监测耐受性诱导的第一步,可以比较不同临床研究的结果。该路线图还可以应用于其他治疗性干预措施,而不仅限于耐受诱导疗法,在这些疗法中,Ag特异性T细胞反应是相关的,例如疫苗接种方法和癌症免疫疗法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号